ADA and MD Anderson team up for Oral Cancer Symposium
A closer look at how dentists, oncologists, head and neck surgeons and other health professionals can and should work together to reduce and prevent cancer.
WHAT/WHO: Working Together Against Oropharyngeal Cancer is a symposium at which experts associated with the American Dental Association (ADA), The University of Texas MD Anderson Cancer Center, Centers for Disease Control and Prevention and University of Chicago Medicine will address the relationship between HPV infection and oropharyngeal cancer. Speakers will present the latest on the rising epidemic of oropharyngeal cancer and the global impact of HPV-related cancers, the potential for the HPV vaccine and eliminating tobacco use to prevent cancer, an update on emerging techniques to treat oropharyngeal cancers, and an overview of the major long-term side effects of current therapies. A panel of survivors will bring a face to oropharyngeal cancer and relate their personal experiences in the cancer continuum from diagnosis to treatment to survivorship, along with their straightforward advocacy for HPV vaccination and ending tobacco use. Attendees from the dental and medical communities are welcome. The symposium will immediately precede ADA 2017 – America’s Dental Meeting®.
WHEN: Wednesday, Oct. 18, 2017, 11 a.m. – 5 p.m. ET
WHERE: Georgia World Congress Center, Atlanta
WHY: The symposium follows an announcement that the ADA and The University of Texas MD Anderson Cancer Center are combining their expertise to focus on increasing human papillomavirus vaccinations and tobacco cessation for oral cancer prevention. Their goal is to help improve patient outcomes through programs aimed at dental and medical professionals and the public.
LEARN MORE: For more information, visit ADA.org/ADA17OralCancer. To register as press, email mediarelations@ada.org.
